Facebook changes policy on pharma page comments

05/31/2011 | Medical Marketing & Media

Drugmakers that do not allow comments on their Facebook pages have until Aug. 15 to enable the comment function, and new pages will be unable to disable the function, according to a May 17 e-mail from Facebook. Branded pages for prescription drugs will be allowed, in some cases, to have the comment function disabled. The FDA is likely to expect drugmakers to report comments regarding adverse events.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ